Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · IEX Real-Time Price · USD
10.57
+0.04 (0.38%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Centessa Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CNTA stock have an average target of 10, with a low estimate of 5.00 and a high estimate of 15. The average target predicts a decrease of -5.39% from the current stock price of 10.57.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CNTA stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $15 | Buy | Maintains | $15 | +41.91% | Apr 1, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $4 → $11 | Hold → Strong Buy | Upgrades | $4 → $11 | +4.07% | Nov 15, 2023 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $4 → $8 | Sell → Hold | Upgrades | $4 → $8 | -24.31% | Oct 26, 2023 |
| SVB Securities | SVB Securities | Buy Maintains $6 → $11 | Buy | Maintains | $6 → $11 | +4.07% | Aug 15, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | -5.39% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
from 6.85M
Revenue Next Year
n/a
EPS This Year
-1.85
from -1.57
EPS Next Year
-1.90
from -1.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 57.3M | 424.2M | 742.4M |
| Avg | n/a | n/a | 42.9M | 195.9M | 337.4M |
| Low | n/a | n/a | 18.3M | 80.2M | 124.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 888.5% | 279.0% |
| Avg | - | - | - | 356.4% | 72.3% |
| Low | - | - | - | 86.8% | -36.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.72 | -1.93 | -0.93 |
| Avg | -1.85 | -1.90 | -1.38 |
| Low | -1.97 | -1.84 | -1.66 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.